Diagnosis and treatment methods for recurrent miscarriage cases.

Area of Science:

• Reproductive Medicine
• Genetics
• Obstetrics

Background:

• Recurrent miscarriage (RM) is defined as three or more consecutive pregnancy losses.
• Established causes include antiphospholipid antibodies, uterine anomalies, and parental chromosomal abnormalities.
• Embryonic aneuploidy is a significant factor in early pregnancy loss.

Purpose of the Study:

• To investigate the role of embryonic aneuploidy in recurrent miscarriage.
• To evaluate the necessity of medical intervention for RM cases attributed to chromosomal abnormalities.
• To highlight the importance of supportive care in managing recurrent pregnancy loss.

Main Methods:

• Review of established causes of recurrent miscarriage.
• Analysis of the prevalence of embryonic aneuploidy in early pregnancy loss.
• Speculative analysis based on existing data regarding karyotype abnormalities in RM patients.

Main Results:

• Embryonic aneuploidy is the primary cause of miscarriage before 10 weeks' gestation.
• Approximately 51% of patients with three or more miscarriages may have experienced them due to abnormal embryonic karyotypes.
• Medical treatment is not indicated for RM caused by abnormal embryonic karyotypes.

Conclusions:

• Abnormal embryonic karyotypes are a major contributor to recurrent miscarriage.
• Management of RM due to aneuploidy should focus on non-pharmacological support.
• Psychological support and 'tender loving care' are vital for successful conception and live birth in these cases.